Concert Pharmaceuticals
CNCE
#7570
Rank
$0.40 B
Marketcap
$8.37
Share price
0.00%
Change (1 day)
78.85%
Change (1 year)

Revenue for Concert Pharmaceuticals (CNCE)

Revenue in 2022 (TTM): $0.04 Million USD

According to Concert Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is $0.04 Million USD. In 2021 the company made a revenue of $32.57 Million USD an increase over the revenue in the year 2020 that were of $7.9 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Concert Pharmaceuticals from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) $0.04 M-99.87%
2021 $32.57 M312.28%
2020 $7.9 M633.7%
2019 $1.07 M-89.75%
2018 $10.5 M-92.7%
2017 $0.14 B82595.98%
2016 $0.17 M-99.74%
2015 $66.72 M678.09%
2014 $8.57 M-66.25%
2013 $25.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
$59.64 B 142,009,423.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
$0.54 M 1,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
$4.15 B 9,899,502.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Ardelyx
ARDX
$0.39 B 948,076.19%๐Ÿ‡บ๐Ÿ‡ธ USA